Evaluation of THC-Related Neuropsychiatric Symptoms Among Adults Aged 50 Years and Older
Abstract This systematic review and metaregression analysis estimates the association between the delta-9-tetrahydrocannabinol (THC) dose of cannabinoid-based medicines and neuropsychiatric adverse events among adults aged 50 years and older. Authors: Latha Velayudhan, Katie Louise McGoohan, Sagnik Bhattacharyya Affiliations: Department of Old Age Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, Division of Academic Psychiatry, King’s College London, London, United Kingdom; Department of Psychosis, Institute of Psychiatry, Psychology, and Neuroscience, Division of Academic Psychiatry, King’s College London, London, United Kingdom License: Copyright
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in